Author

Yunfei Li

Observed name: Yun-Fei Li

Institution: Tianjin University of Traditional Chinese Medicine

Observed institutions: Tianjin University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College

ORCID: 0000-0002-5287-0003

Observed ORCID: 0000-0002-5287-0003

OpenAlex ID: A5100461855

Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles

2013 · Feifei Yang, Wei Huang, et al. · Biomaterials · 68

Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases

2024 · Hui Zhi, Hui Fu, et al. · Frontiers in Immunology · 13

Advances in chemically modified HSA as a multifunctional carrier for transforming cancer therapy regimens

2025 · Zheng Sun, Hui Fu, et al. · International Journal of Biological Macromolecules · 11

Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway

2024 · Ni Fan, Feng Zhao, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 11

A Novel Monomethoxy Polyethylene Glycol–Polylactic Acid Polymeric Micelles with Higher Loading Capacity for Docetaxel and Well-Reconstitution Characteristics and Its Anti-metastasis Study

2012 · Yunfei Li, Feifei Yang, et al. · Chemical and Pharmaceutical Bulletin · 9

Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome

2020 · Xiaowei Wang, Yunfei Li, et al. · Pharmaceutical Development and Technology · 8

Docetaxel-Encapsulating Small-Sized Polymeric Micelles with Higher Permeability and Its Efficacy on the Orthotopic Transplantation Model of Pancreatic Ductal Adenocarcinoma

2014 · Yunfei Li, Peiran Li, et al. · International Journal of Molecular Sciences · 8

Pharmacological effects and mechanisms of YiYiFuZi powder in chronic heart disease revealed by metabolomics and network pharmacology

2023 · Yuming Wang, Xue Li, et al. · Frontiers in Molecular Biosciences · 5

[Current status of non-viral vectors for siRNA delivery].

2011 · Fei-Fei Yang, Wei Huang, et al. · PubMed · 5

Cell-penetrating peptide TAT modified chitosan for siRNA delivery

2013 · Feifei Yang, Yunfei Li, et al. · Journal of Controlled Release · 3

Co-encapsulation of an AKT Inhibitor Enhances the Tumor-cell Selectivity of STING Agonists in Co-delivery Liposomes

2025 · Ziyu Ge, Qiang Zhang, et al. · Pharmaceutical Research · 2

Anti-tumor effects in mice induced by Bcl-2 targeted siRNA delivered by TAT- g- CS vector

2015 · Wei Huang, Feifei Yang, et al. · Journal of Controlled Release · 2

Overcoming cholesterol-induced pulmonary toxicity: plant sterols and natural saponins as bioactive alternatives in inhalable liposomes for active carrier-mediated synergistic therapy

2026 · Chunfang Zhao, Tingting Ma, et al. · International Journal of Pharmaceutics

Marine Bromophenol Derivatives as a Novel Class of Potent Small-Molecule STING Agonists

2026 · Manqing Tang, Qiuhui Guo, et al. · Current Issues in Molecular Biology

Works count: 15

Citation count: 158

H-index: 8

I10-index: 5